Update: Selective adrenal venous sampling (AVS) – Indication, technique, and significance

Abstract

Background Primary aldosteronism (PA) is the most common detectable cause of secondary hypertension. The majority of patients have either an adrenal aldosterone-producing adenoma (APA) or bilateral adrenal hyperplasia (BAH) demanding different therapeutic approaches. Screening tests and imaging cannot reliably distinguish between a unilateral or bilateral PA.

Methods This review article gives an overview concerning etiology, diagnostics, and therapeutic options of PA, and reviews the indication, the technique, and relevance of selective adrenal venous sampling (AVS) in the context of the current literature and the authors’ experience.

Results AVS can verify or exclude a unilaterally dominated secretion with a high success rate. Patients with PA and a unilateral APA can be treated curatively by adrenalectomy.

Conclusions AVS is an established diagnostic examination for differentiation of unilateral from bilateral adrenal disease in patients with PA.

Key Points:

• Selective adrenal venous sampling (AVS) is a safe, reliable, and minimally invasive method to detect a unilateral or bilateral adrenal adrenal gland disease.

• Verification of lateralization by AVS has direct therapeutic relevance for patients with primary aldosteronism (PA).

• AVS can be performed with low radiation exposure, without contrast medium, and with a high success rate when performed by an experienced interventional radiologist.

Citation Format

• Loberg C, Antoch G, Stegbauer J et al. Update: Selective adrenal venous sampling (AVS) – Indication, technique, and significance. Fortschr Röntgenstr 2021; 193: 658 – 666

Key words

adrenal gland - interventional procedures - angiography - blood - hypertension

Publikationsverlauf

Eingereicht: 03. Juli 2020

Angenommen: 19. Oktober 2020

Artikel online veröffentlicht:
16. Dezember 2020

• References

• 1 Rossi GP, Bernini G, Caliumi C. et al. A prospective study of the prevalence of primary aldosteronism in 1125 hypertensive patients. J Am Coll Cardiol 2006; 48: 2293-2300
• 2 Douma S, Petidis K, Doumas M. et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-1926
• 3 Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol 2007; 66: 607-618
• 4 Heinrich DA, Adolf C, Rump LC. et al. Primary Hyperaldosteronism: key characteristics at diagnosis: a trend toward milder forms. Eur J Endocrinol 2018; 178: 605-611
• 5 Martell-Claros N, Abad-Cardiel M, Alvarez-Alvarenz B. et al. Primary aldosteronism and its various clinical scenarios. J Hypertens 2015; 33: 1226-1232
• 6 Funder JW, Carey RM, Mantero F. et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916
• 7 Prejbisz A, Warchol-Celinska E, Lenders JW. et al. Cardiovasc. Risk in Primary Hyperaldosteronism. Horm Metab Res 2015; 47: 973-980
• 8 Rossi GP, Seccia TM, Maiolino G. et al The cardiovasculars consequences of hyperaldosteronism. Ann Endocrinol 2020 [online first]
• 9 Pillai PR, Griffith M, Schwarcz MD. et al. Primary Hyperaldosteronism: Cardiovasc. Risk, Diagnosis and Management. Cardiol Rev 2020; 28: 84-91
• 10 Terzolo M, Stigliano A, Chiodini I. et al. AME position statement on adrenal incidentaloma. Eur J Endocrinol 2011; 164: 851-870
• 11 Chiloiro S, Giampietro A, Raffaelli M. et al. Synchronous bilateral adrenalectomy in ACTH-dependent hypercortisolism: predictors, biomarkers and outcomes. Endocrine 2019; 66: 642-649
• 12 Vonend O, Quack I, Rump LR. Aldosteron und Hypertonie. Wien klin Wochenschr 2010; 122: 65-74
• 13 Song Y, Yang S, He W. et al. Confirmatory Tests for the Diagnosis of Primary Hyperaldosteronism: A Prospective Diagnostic Accuracy Study. Chonquing Primary Aldosteronism Study (CONPASS) Group. Hypertension 2018; 71: 118-124
• 14 Delivanis DA, Vassiliadi DA, Tsagarakis S. Adrenal Imaging in Patients with Endocrine Hypertension. Endocrinol Metab Clin N Am 2019; 48: 667-680
• 15 Boland GW, Lee MJ, Gazelle GS. et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. Am J Roentgenol 1998; 171: 201-204
• 16 Korobkin M, Brodeur FJ, Francis IR. et al. CT Time – attenuation washout curves of adrenal adenoma s and nonadenomas. Am J Roentgenol 1998; 170: 747-752
• 17 Seo JM, Park BK, Park SY. et al. Characterization of lipid – poor adrenal adenoma: chemical shift MRI and wash-out CT. Am J Roentgenol 2014; 202: 1043-1050
• 18 Siegelman ES. Adrenal MRI: Techniques and clinical applications. L Magn Reson Imaging 2012; 36: 272-285
• 19 Stowasser M, Gordon RD, Rutherford JC. et al. Diagnosis and management of primary aldosteronism. J Renin Angiotensin Aldosterone Syst 2001; 2: 156-169
• 20 Blondin D, Quark I, Haase M. et al. Indikationen und Technik der selektiven Nebennierenvenenblutentnahme. RöFo 2015; 187: 19-28
• 21 England RW, Geer EB, Deipolyi AR. Role of Venous Sampling in the Diagnosis of Endocrine Disorders. J Clin Med 2018; 7: 114
• 22 Yeh MW, Duh QY. Chapter 41: The Adrenal Glands. In: Townsend CM. Sabiston Textbook Of Surgery. Sauders: Elsevier; 2008. Available on https://thoracickey.com/the-adrenal-glands/
• 23 Cesmebasi A, Du Plessis M, Iannatuono M. et al. A review of the anatomy and clinical significance of adrenal veins. Clin Anat 2014; 27: 1253-1263
• 24 Patel IJ, Davidson JC, Nikolic B. et al. Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in percutaneous Image-guides Interventions. JVIR 2019; 30: 1168-1184
• 25 Mailhot JP, Traistaru M, Soulez G. et al. Adrenal Vein Sampling in Primary Hyperaldosteronism: Sensitivity and Specificity of Basal Cortisol and Aldosterone Ratios to Confirm Cathererization of the Adrenal Vein. Radiology 2015; 277: 887-894
• 26 Ueland GA, Methlie P, Jøssang DE. et al. Adrenal Venous Sampling for Assessment of Autonomous Cortisol Secretion. J Clin Endocrinol Metab 2018; 103: 4553-4560
• 27 Rossi GP, Auchus RJ, Brown M. et al. An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism. Hypertension 2014; 63: 151-160
• 28 Kahn SL, Angle FJ. Adrenal Vein Sampling. Tech Vasc Interv Radiol 2010; 13: 110-125
• 29 Satani N, Ota H, Seiji K. et al. Intra-adrenal aldosterone secretion: Segmental adrenal venous sampling for localization. Radiology 2016; 278: 265-274
• 30 Daunt N. Adrenal Vein Sampling: How to Make It Quick, Easy, and Successful. RadioGraphics 2005; 25: 143-158
• 31 Doppmann JL, Gill JR. Hyperaldosteronism: Sampling the Adrenal Veins. Radiology 1996; 198: 309-312
• 32 Cesari M, Ceolotto G, Rossitto G. et al. The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua). High Blood Press Cardiovasc Pre 2017; 24: 167-170
• 33 Funder JW, Carey RM, Mantero F. et al. The Management of Primary Aldosteronism:Case Detection, Diagnosis, and Treatment:An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 1889-1916
• 34 Rossi GP, Barisa M, Allolio B. et al. The adrenal vein sampling international study AVIS for identifying the major subtypes of primary aldosteronism. J Clin Endocrinol Metab 2012; 97: 1606-1614
• 35 Monticone S, Satoh F, Dietz AS. et al. Clinical Management and Outcomes of adrenal Hemorrhage Following Adrenal Vein Sampling in Primary hyperaldosteronism. Hypertension 2016; 67: 146-152
• 36 Lim V, Guo Q, Grant CS. et al. Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism. J Clin Endocrinol Metab 2014; 99: 2712-2719
• 37 Vonend O, Ockenfels N, Gao X. et al. Adrenal venous sampling: evaluation of the German Conn’s registry. Hypertension 2011; 57: 990-995
• 38 Fuss CT, Treitl M, Rayes N. et al. Radiation exposure of adrenal vein sampling: a German Multicenter Study. Eur J Endocrinol 2018; 179: 261-267
• 39 Lupi A, Battistel M, Barbiero G. et al. Simultaneous bilateral adrenal vein sampling for primary aldosteronism: useful tips to make it simple and safe. Eur Radiol 2019; 11: 6330-6335
• 40 Noda Y, Goshima S, Nagata S. et al. Utility of microcatheter in adrenal venous sampling for primary aldosteronism. Br J Radiol 2020; 93: 1109
• 41 Rossitto G, Maiolino G, Lenzini L. et al. Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide. Surgery 2018; 163: 789-795
• 42 Kline GA, So B, Dias VC. et al. Catheterization during adrenal vein sampling for primary aldosteronism: failure to use (1–24) ACTH may increase apparent failure rate. J Clin Hypertens (Greenwich) 2013; 15: 480-484
• 43 Deinum J, Groenewoud H, van der Wilt GJ. et al. Adrenal venous sampling: cosyntropin stimulation or not?. Eur J Endocrin 2019; 181: D15-D26
• 44 Onozawa S, Murata S, Tajima H. et al. Evaluation of right adrenal vein cannulation by computed tomography angiography in 140 consecutive patients undergoing adrenal venous sampling. Eur J Endocrinol 2014; 170: 601-608
• 45 Meyrignac O, Arcis É, Delchier MC. et al Impact of cone beam CT on adrenal vein sampling in primary aldosteronism. Eur J Radiol 2020; 124 [online first]
• 46 Ladurner R, Sommerey S, Buechner S. et al. Accuracy of adrenal imaging and adrenal venous sampling in diagnosing unilateral primary aldosteronism. Eur J Clin Invest 2017; 47: 372-377
• 47 Dekkers T, Prejbisz A, Kool LJ. et al. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: An outcome-based randomised diagnostic trial. Lancet Diabetes Endocrinol 2016; 4: 739-746
• 48 Beuschlein F, Mulatero P, Asbach E. et al. The SPARTACUS Trial: Controversies and Unresolved Issues. Horm Metab Res 2017; 49: 936-942
• 49 Sk2-Leitlinie Operative Therapie von Nebennierentumoren. Langversion; Dezember 2017; AWMF-Register-Nummer: 088/008. https://www.awmf.org/leitlinien/detail/ll/088-008.html (Zugriff am: 22.08.2020)
• 50 Tomaschitz A, Dobnig H. Primärer Hyperaldosteronismus – die häufigste monokausale Ursache der essenziellen Hypertonie. J Clin Endocrinology and Metabolism 2009; 2: 14-21
• 51 Vorselaars WMCM, Nell S, Postma EL. et al. Clinical Outcomes After Unilateral Adrenalectomy for Primary Aldosteronism. JAMA Surg 2019; 154: e185842
• 52 Liang KW, Jahangiri Y, Tsao TF. et al. Effectiveness of Thermal Ablation for Aldosterone-Producing Adrenal Adenoma: A Systematic Review and Meta-Analysis of Clinical and Biochemical Parameters. J Vasc Interv Radiol 2019; 30: 1335-1342